Evonik to expand production capacities in China
Production scheduled to begin at the end of 2011
Advertisement
Demand for triacetonamine derivatives (TAA derivatives) has kept rising for several years. Evonik Industries is taking advantage of the economic opportunities afforded by this situation and is considerably expanding its production capacities for these special derivatives in China. The foundations for a new plant will be laid as early as this year.
Currently, Evonik produces the derivatives in a joint venture Evonik Tianda (Liaoyang) Chemical Additive Co., Ltd. at the Liaoyang site in northeaster China. The existing production capacities are to be moved within the Liaoyang region to the Aromatic Site (LAS), one of the country's largest petrochemical sites, and will also be significantly increased. Full production is scheduled to commence in the fourth quarter of 2011.
Most read news
Other news from the department manufacturing
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.